Abstract
Summary
Carbetocin is an oxytocin agent used to control postpartum hemorrhage and bleeding after giving birth.
The global market for Carbetocin Injection was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Middle East and Africa is expected to experience the highest growth in the market during the forecast period.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Carbetocin Injection, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Carbetocin Injection by region & country, by Type, and by Application.
The Carbetocin Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carbetocin Injection.
Market Segmentation
By Company
Ferring Pharmaceuticals
Hybio Pharmaceutical
Chengdu Shengnuo Biotechnology
Boya Bio
Tibet Aim Pharm.Inc(Aim Pharm)
Pfizer
Beacon Pharmaceuticals Ltd.
Segment by Type:
Original Drug
Generic Drug
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Carbetocin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Carbetocin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Carbetocin Injection in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Carbetocin Injection was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Middle East and Africa is expected to experience the highest growth in the market during the forecast period.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Carbetocin Injection, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Carbetocin Injection by region & country, by Type, and by Application.
The Carbetocin Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carbetocin Injection.
Market Segmentation
By Company
Ferring Pharmaceuticals
Hybio Pharmaceutical
Chengdu Shengnuo Biotechnology
Boya Bio
Tibet Aim Pharm.Inc(Aim Pharm)
Pfizer
Beacon Pharmaceuticals Ltd.
Segment by Type:
Original Drug
Generic Drug
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Carbetocin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Carbetocin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Carbetocin Injection in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Carbetocin Injection Product Introduction
1.2 Global Carbetocin Injection Market Size Forecast
1.2.1 Global Carbetocin Injection Sales Value (2019-2030)
1.2.2 Global Carbetocin Injection Sales Volume (2019-2030)
1.2.3 Global Carbetocin Injection Sales Price (2019-2030)
1.3 Carbetocin Injection Market Trends & Drivers
1.3.1 Carbetocin Injection Industry Trends
1.3.2 Carbetocin Injection Market Drivers & Opportunity
1.3.3 Carbetocin Injection Market Challenges
1.3.4 Carbetocin Injection Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Carbetocin Injection Players Revenue Ranking (2023)
2.2 Global Carbetocin Injection Revenue by Company (2019-2024)
2.3 Global Carbetocin Injection Players Sales Volume Ranking (2023)
2.4 Global Carbetocin Injection Sales Volume by Company Players (2019-2024)
2.5 Global Carbetocin Injection Average Price by Company (2019-2024)
2.6 Key Manufacturers Carbetocin Injection Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Carbetocin Injection Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Carbetocin Injection
2.9 Carbetocin Injection Market Competitive Analysis
2.9.1 Carbetocin Injection Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Carbetocin Injection Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carbetocin Injection as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Original Drug
3.1.2 Generic Drug
3.2 Global Carbetocin Injection Sales Value by Type
3.2.1 Global Carbetocin Injection Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Carbetocin Injection Sales Value, by Type (2019-2030)
3.2.3 Global Carbetocin Injection Sales Value, by Type (%) (2019-2030)
3.3 Global Carbetocin Injection Sales Volume by Type
3.3.1 Global Carbetocin Injection Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Carbetocin Injection Sales Volume, by Type (2019-2030)
3.3.3 Global Carbetocin Injection Sales Volume, by Type (%) (2019-2030)
3.4 Global Carbetocin Injection Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.2 Global Carbetocin Injection Sales Value by Application
4.2.1 Global Carbetocin Injection Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Carbetocin Injection Sales Value, by Application (2019-2030)
4.2.3 Global Carbetocin Injection Sales Value, by Application (%) (2019-2030)
4.3 Global Carbetocin Injection Sales Volume by Application
4.3.1 Global Carbetocin Injection Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Carbetocin Injection Sales Volume, by Application (2019-2030)
4.3.3 Global Carbetocin Injection Sales Volume, by Application (%) (2019-2030)
4.4 Global Carbetocin Injection Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Carbetocin Injection Sales Value by Region
5.1.1 Global Carbetocin Injection Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Carbetocin Injection Sales Value by Region (2019-2024)
5.1.3 Global Carbetocin Injection Sales Value by Region (2025-2030)
5.1.4 Global Carbetocin Injection Sales Value by Region (%), (2019-2030)
5.2 Global Carbetocin Injection Sales Volume by Region
5.2.1 Global Carbetocin Injection Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Carbetocin Injection Sales Volume by Region (2019-2024)
5.2.3 Global Carbetocin Injection Sales Volume by Region (2025-2030)
5.2.4 Global Carbetocin Injection Sales Volume by Region (%), (2019-2030)
5.3 Global Carbetocin Injection Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Carbetocin Injection Sales Value, 2019-2030
5.4.2 North America Carbetocin Injection Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Carbetocin Injection Sales Value, 2019-2030
5.5.2 Europe Carbetocin Injection Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Carbetocin Injection Sales Value, 2019-2030
5.6.2 Asia Pacific Carbetocin Injection Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Carbetocin Injection Sales Value, 2019-2030
5.7.2 South America Carbetocin Injection Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Carbetocin Injection Sales Value, 2019-2030
5.8.2 Middle East & Africa Carbetocin Injection Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Carbetocin Injection Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Carbetocin Injection Sales Value
6.2.1 Key Countries/Regions Carbetocin Injection Sales Value, 2019-2030
6.2.2 Key Countries/Regions Carbetocin Injection Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Carbetocin Injection Sales Value, 2019-2030
6.3.2 United States Carbetocin Injection Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Carbetocin Injection Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Carbetocin Injection Sales Value, 2019-2030
6.4.2 Europe Carbetocin Injection Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Carbetocin Injection Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Carbetocin Injection Sales Value, 2019-2030
6.5.2 China Carbetocin Injection Sales Value by Type (%), 2023 VS 2030
6.5.3 China Carbetocin Injection Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Carbetocin Injection Sales Value, 2019-2030
6.6.2 Japan Carbetocin Injection Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Carbetocin Injection Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Carbetocin Injection Sales Value, 2019-2030
6.7.2 South Korea Carbetocin Injection Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Carbetocin Injection Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Carbetocin Injection Sales Value, 2019-2030
6.8.2 Southeast Asia Carbetocin Injection Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Carbetocin Injection Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Carbetocin Injection Sales Value, 2019-2030
6.9.2 India Carbetocin Injection Sales Value by Type (%), 2023 VS 2030
6.9.3 India Carbetocin Injection Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Ferring Pharmaceuticals
7.1.1 Ferring Pharmaceuticals Company Information
7.1.2 Ferring Pharmaceuticals Introduction and Business Overview
7.1.3 Ferring Pharmaceuticals Carbetocin Injection Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Ferring Pharmaceuticals Carbetocin Injection Product Offerings
7.1.5 Ferring Pharmaceuticals Recent Development
7.2 Hybio Pharmaceutical
7.2.1 Hybio Pharmaceutical Company Information
7.2.2 Hybio Pharmaceutical Introduction and Business Overview
7.2.3 Hybio Pharmaceutical Carbetocin Injection Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Hybio Pharmaceutical Carbetocin Injection Product Offerings
7.2.5 Hybio Pharmaceutical Recent Development
7.3 Chengdu Shengnuo Biotechnology
7.3.1 Chengdu Shengnuo Biotechnology Company Information
7.3.2 Chengdu Shengnuo Biotechnology Introduction and Business Overview
7.3.3 Chengdu Shengnuo Biotechnology Carbetocin Injection Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Chengdu Shengnuo Biotechnology Carbetocin Injection Product Offerings
7.3.5 Chengdu Shengnuo Biotechnology Recent Development
7.4 Boya Bio
7.4.1 Boya Bio Company Information
7.4.2 Boya Bio Introduction and Business Overview
7.4.3 Boya Bio Carbetocin Injection Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Boya Bio Carbetocin Injection Product Offerings
7.4.5 Boya Bio Recent Development
7.5 Tibet Aim Pharm.Inc(Aim Pharm)
7.5.1 Tibet Aim Pharm.Inc(Aim Pharm) Company Information
7.5.2 Tibet Aim Pharm.Inc(Aim Pharm) Introduction and Business Overview
7.5.3 Tibet Aim Pharm.Inc(Aim Pharm) Carbetocin Injection Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Tibet Aim Pharm.Inc(Aim Pharm) Carbetocin Injection Product Offerings
7.5.5 Tibet Aim Pharm.Inc(Aim Pharm) Recent Development
7.6 Pfizer
7.6.1 Pfizer Company Information
7.6.2 Pfizer Introduction and Business Overview
7.6.3 Pfizer Carbetocin Injection Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Pfizer Carbetocin Injection Product Offerings
7.6.5 Pfizer Recent Development
7.7 Beacon Pharmaceuticals Ltd.
7.7.1 Beacon Pharmaceuticals Ltd. Company Information
7.7.2 Beacon Pharmaceuticals Ltd. Introduction and Business Overview
7.7.3 Beacon Pharmaceuticals Ltd. Carbetocin Injection Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Beacon Pharmaceuticals Ltd. Carbetocin Injection Product Offerings
7.7.5 Beacon Pharmaceuticals Ltd. Recent Development
8 Industry Chain Analysis
8.1 Carbetocin Injection Industrial Chain
8.2 Carbetocin Injection Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Carbetocin Injection Sales Model
8.5.2 Sales Channel
8.5.3 Carbetocin Injection Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer